DCF — CAPITAL REGION MEDICAL CENTER
Enterprise Value: $-596.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-596.6M
Enterprise Value
$-183.9M
PV of Cash Flows
$-412.6M
PV of Terminal Value
$-664.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $230.7M | $-39.8M | -17.0% | $-49.5M | $-45.0M |
| Year 2 | $237.6M | $-38.6M | -16.0% | $-48.7M | $-40.2M |
| Year 3 | $244.8M | $-37.3M | -15.0% | $-47.7M | $-35.8M |
| Year 4 | $252.1M | $-37.2M | -15.0% | $-47.8M | $-32.7M |
| Year 5 | $259.7M | $-37.6M | -14.0% | $-48.6M | $-30.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-596.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$224.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17742451656065716
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5